Interpreting treatment-induced blood pressure reductions measured by ambulatory blood pressure monitoring

Journal of Human Hypertension

Volumn 27, Issue 12, 2013, Pages 715-720

  Schmieder, R E ^a   Ruilope, L M ^b   Ott, C ^a   Mahfoud, F ^c   Bohm M ^c  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^c SAARLAND UNIVERSITY   (Germany)

Author keywords

Ambulatory blood pressure; Antihypertensive therapy; Clinic blood pressure

Indexed keywords

ANTIHYPERTENSIVE AGENT; DARUSENTAN;

ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL (TOPIC); HEART LEFT VENTRICLE HYPERTROPHY; HYPERTENSION; MORTALITY; MULTIPLE ORGAN FAILURE; REVIEW; RISK REDUCTION;

BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; HUMANS; HYPERTENSION;

EID: 84887620830     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2013.39     Document Type: Review

References (33)

1. Clement DL, De Buyzere ML, De Bacquer DA, de Leeuw PW, Duprez DA, Fagard RH et al. Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. N Engl J Med 2003; 348(24): 2407-2415.
2. Dolan E, Stanton A, Thijs L, Hinedi K, Atkins N, McClory S et al. Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study. Hypertension 2005; 46(1): 156-161.
3. Minutolo R, Agarwal R, Borrelli S, Chiodini P, Bellizzi V, Nappi F et al. Prognostic role of ambulatory blood pressure measurement in patients with nondialysis chronic kidney disease. Arch Intern Med 2011; 171(12): 1090-1098.
4. Fagard RH, Staessen JA, Thijs L.. Relationships between changes in left ventricular mass and in clinic and ambulatory blood pressure in response to antihypertensive therapy. J hypertens 1997; 15(12 Pt 1): 1493-1502.
5. Staessen JA, Thijs L, Fagard R, O'Brien ET, Clement D, de Leeuw PW et al. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators. JAMA 1999; 282(6): 539-546.
6. Krause T, Lovibond K, Caulfield M, McCormack T, Williams B.. Management of hypertension: summary of NICE guidance. BMJ 2011; 343: d4891.
7. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G et al. 2007Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 28(12): 1462-1536.
8. Head GA, McGrath BP, Mihailidou AS, Nelson MR, Schlaich MP, Stowasser M et al. Ambulatory blood pressure monitoring in Australia: 2011 consensus position statement. J Hypertens 2012; 30(2): 253-266.
9. Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeldt D, Julius S et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 1998; 351(9118): 1755-1762.
10. Cushman WC, Evans GW, Byington RP, Goff Jr DC, Grimm Jr RH, Cutler JA et al. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med 2010; 362(17): 1575-1585.
11. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998; 317(7160): 703-713.
12. de la Sierra A, Segura J, Banegas JR, Gorostidi M, de la Cruz JJ, Armario P et al. Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring. Hypertension 2011; 57(5): 898-902.
13. Gorostidi M, Sobrino J, Segura J, Sierra C, de la Sierra A, Hernandez del Rey R et al. Ambulatory blood pressure monitoring in hypertensive patients with high cardiovascular risk: a cross-sectional analysis of a 20,000-patient database in Spain. J Hypertens 2007; 25(5): 977-984.
14. Puchades R, Ruiz-Nodar JM, Blanco F, Rodriguez F, Gabriel R, Suarez C.. White-coat hypertension in the elderly. Echocardiographic analysis. A substudy of the EPICARDIAN project. Rev Esp Cardiol 2010; 63(11): 1377-1381.
15. Fagard RH, Cornelissen VA. Incidence of cardiovascular events in white-coat, masked and sustained hypertension versus true normotension: a meta-analysis. J Hypertens 2007; 25(11): 2193-2198.
16. Franklin SS, Thijs L, Hansen TW, Li Y, Boggia J, Kikuya M et al. Significance of white-coat hypertension in older persons with isolated systolic hypertension: a meta-analysis using the International Database on Ambulatory Blood Pressure Monitoring in Relation to Cardiovascular Outcomes population. Hypertension 2012; 59(3): 564-571.
17. Lehmann MV, Zeymer U, Dechend R, Kaiser E, Hagedorn I, Deeg E et al. Ambulatory blood pressure monitoring: is it mandatory for blood pressure control in treated hypertensive patients? Int J Cardiol 2013; 13: 00269-6accepted.
18. Bjorklund K, Lind L, Zethelius B, Andren B, Lithell H.. Isolated ambulatory hypertension predicts cardiovascular morbidity in elderly men. Circulation 2003; 107(9): 1297-1302.
19. Ogedegbe G, Agyemang C, Ravenell JE.. Masked hypertension: evidence of the need to treat. Curr Hypertens Rep 2010; 12(5): 349-355.
20. Bobrie G, Clerson P, Menard J, Postel-Vinay N, Chatellier G, Plouin PF.. Masked hypertension: a systematic review. J Hypertens 2008; 26(9): 1715-1725.
21. Pierdomenico SD, Cuccurullo F.. Prognostic value of white-coat and masked hypertension diagnosed by ambulatory monitoring in initially untreated subjects: an updated meta analysis. Am J Hypertens 2011; 24(1): 52-58.
22. Bidani AK, Griffin KA, Epstein M.. Hypertension and chronic kidney disease progression: why the suboptimal outcomes? Am J Med 2012; 125(11): 1057-1062.
23. Mancia G, Parati G.. Office compared with ambulatory blood pressure in assessing response to antihypertensive treatment: a meta-analysis. J Hypertens 2004; 22(3): 435-445.
24. Cheng XR, Wang Y, Hu B, Jia X, Li W.. Comparison of clinic and ambulatory blood pressure in response to antihypertensive drugs in Chinese patients. Biomed Environ Sci 2007; 20(4): 279-283.
25. Ishikawa J, Carroll DJ, Kuruvilla S, Schwartz JE, Pickering TG.. Changes in home versus clinic blood pressure with antihypertensive treatments: a meta-analysis. Hypertension 2008; 52(5): 856-864.
26. Staessen JA, Byttebier G, Buntinx F, Celis H, O'Brien ET, Fagard R.. Antihypertensive treatment based on conventional or ambulatory blood pressure measurement. A randomized controlled trial. Ambulatory Blood Pressure Monitoring and Treatment of Hypertension Investigators. JAMA 1997; 278(13): 1065-1072.
27. Bakris GL, Lindholm LH, Black HR, Krum H, Linas S, Linseman JV et al. Divergent results using clinic and ambulatory blood pressures: report of a darusentanresistant hypertension trial. Hypertension 2010; 56(5): 824-830.
28. Doumas M, Anyfanti P, Bakris G.. Should ambulatory blood pressure monitoring be mandatory for future studies in resistant hypertension: a perspective. J Hypertens 2012; 30(5): 874-876.
29. Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, Bohm M.. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet 2010; 376(9756): 1903-1909.
30. Mancia G, Zanchetti A, Agabiti-Rosei E, Benemio G, De Cesaris R, Fogari R et al. Ambulatory blood pressure is superior to clinic blood pressure in predicting treatment-induced regression of left ventricular hypertrophy. Sample study group. Study on ambulatory monitoring of blood pressure and lisinopril evaluation. Circulation 1997; 95: 1464-1470.
31. Smith PA, Graham LN, Mackintosh AF, Stoker JB, Mary DA.. Sympathetic neural mechanisms in white-coat hypertension. J Am Coll Cardiol 2002; 40(1): 126-132.
32. Grassi G, Seravalle G, Brambilla G, Mancia G.. The sympathetic nervous system and new nonpharmacologic approaches to treating hypertension: a focus on renal denervation. Can J Cardiol 2012; 28(3): 311-317.
33. Sega R, Facchetti R, Bombelli M, Cesana G, Corrao G, Grassi G et al. Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study. Circulation 2005; 111(14): 1777-1783.